Severe Covid-19 illness in children is significant but less frequent than in adults
Focus:
-
![Praha Vaccines]()
Novavax buys Praha Vaccines for Covid-19 vaccine manufacturing
-
![CCR4 antagonists]()
CCR4 antagonists have potential as combinatorial agents for immuno-oncology therapies
-
![covid-19 india]()
Despite the recent surge in the daily confirmed cases of Covid-19 in India, average case fatality rate is relatively low
-
![Chloroquine covid-19]()
Bayer donates millions of chloroquine tablets: are they useful?
-
![Generics Covid-19]()
Generics and the Covid-19 pandemic: Q&A with Accord’s Dr Anthony Grosso
-
![opioid use disorder]()
Covid-19 pandemic changing how opioid use disorder can be treated for the better
Most Read
- Generics and the Covid-19 pandemic: Q&A with Accord’s Dr Anthony Grosso
- Rapid Micro Biosystems raises $120m: improving contamination testing in pharma
- Takeda-Orifarm deal: another divestiture for the Japanese pharma giant
- Q&A: Disrupting DNA synthesis with Twist’s Emily Leproust
- Pharma Technology Focus: treating zebras
Company A-Z
Latest Content
7P Solutions Hires Senior Level New Business Development Executive to Help Manage Growth and Additional Sales
7P has hired Drew Hecht as their new Vice President of Pharmaceutical Solutions. Drew joins a team of motivated executives with a strong presence in the security and transportation risk management industry.
Takara Bio’s Center for Gene and Cell Therapy Processing II, Shiga
Takara Bio opened its new facility, the Center for Gene and Cell Therapy Processing II (CGCPII), in Shiga, Japan.
Rotovalve Light
Rotovalve Light is a rotary valve for the pharmaceutical industry, designed to feed and continuously control the discharged flow, helping the product to be discharged homogeneously thanks to rotary alternating motion.
Novartis’ AveXis agrees to manufacture US researcher Covid-19 vaccine
Novartis unit AveXis has entered into a manufacturing agreement with researchers at Massachusetts Eye and Ear and Massachusetts General Hospital in the US to produce a genetic vaccine against Covid-19, named AAVCOVID.
GSK plans to produce one billion pandemic vaccine adjuvant doses
GlaxoSmithKline (GSK) is set to produce one billion doses of its pandemic vaccine adjuvant system next year to support adjuvanted Covid-19 vaccine candidates development.
Cremer to Exhibit at Interpack on 25 February to 3 March 2021
Cremer is pleased to announce it will be exhibiting at Interpack in Düsseldorf, Germany on 25 February to 3 March 2021.
Cold or Warm Advanced Cleaning Mechanisms for Proteins?
The question: Many of your Tergazyme related TechNotes and recommendations include warm temperatures, which can still denature some hormones and proteins, causing cleaning problems.
Novavax buys Praha Vaccines for Covid-19 vaccine manufacturing
Biotechnology firm Novavax has acquired Czech Republic-based Praha Vaccines for about $167m to support the manufacture of its Covid-19 vaccine candidate, NVX‑CoV2373.
Latest News
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Close
Close
Close
Go Top